Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity

Barbara Ludolph1 Department of Medicine, Medical Clinic I, University Hospital RTWH AachenGermany

Wilhelm Bloch2 Department of Molecular and Cellular Sport Medicine, Sport University CologneGermany

Malte Kelm1 Department of Medicine, Medical Clinic I, University Hospital RTWH AachenGermany

Rainer Schulz3 Institute of Pathophysiology, Medical School, University of EssenGermany

Petra Kleinbongard1 Department of Medicine, Medical Clinic I, University Hospital RTWH AachenGermanyCorrespondence[email protected]

Pages 1069-1073 | Published online: 28 Dec 2022

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

BhattacharyyaMRaySBhattacharyaSChaperone activity and prodan binding at the self-associating domain of erythroid spectrinJ Biol Chem20043155080815492010
PubMedGoogle Scholar
CiccoGPirrelliARed blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertensionClin Hemorheol Microcirc1999211697710711739
PubMed Web of Science ®Google Scholar
CooperKJMartinPDDaneALLack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjectsBr J Clin Pharmacol20035594912534645
PubMed Web of Science ®Google Scholar
De La CruzJPPaezMVCarmonaJAAntiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leukocytesBr J Pharmacol199912815384410602334
PubMed Web of Science ®Google Scholar
DejamAKleinbongardPRassafTThiols enhance NO formation from nitrate photolysisFree Radic Biol Med2003351551914680678
PubMedGoogle Scholar
EndresMLaufsUEffects of stains on endothelium and signaling mechanismsStroke20043515
Web of Science ®Google Scholar
FeelischMRassafTMnaimnehSConcomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivoFASEB J20021617758512409320
PubMed Web of Science ®Google Scholar
FörstermannUBoisselJ-PKleinertHExpressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III)FASEB J199812773909657518
PubMed Web of Science ®Google Scholar
HermanAGMoncadaSTherapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosisEur Heart J20052619455515911567
PubMed Web of Science ®Google Scholar
JubelinBCGiermanJLErythrocytes may synthesize their own nitric oxideAm J Hypertens19969121498972893
PubMed Web of Science ®Google Scholar
KadriZMaouche-ChretienLRookeHMPhosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivationMoll Cell Biol200525741222
PubMed Web of Science ®Google Scholar
KleinbongardPDejamALauerTPlasma nitrite reflects constitutive nitric oxide synthase activity in mammalsFree Radic Biol Med200335790614583343
PubMed Web of Science ®Google Scholar
KleinbongardPSchulzRRassafTRed blood cells express a functional endothelial nitric oxide synthaseBlood200610729435116368881
PubMed Web of Science ®Google Scholar
KohnoMMurakawaKYasunariKImprovement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patientsMetabolism199746287919054471
PubMed Web of Science ®Google Scholar
LaufsUBeyond lipid-lowering: effects of statins on endothelial nitric oxideEur J Clin Pharmacol2003587193112634978
PubMed Web of Science ®Google Scholar
MchedlishviliGMaedaNA determinant of blood fluidity in narrow microvesselsJpn J Physiol200151193011281993
PubMedGoogle Scholar
NomaKOyamaNLiaoJKPhysiological role of ROCKs in the cardiovascular systemAm J Physiol Cell Physiol2006290C661C66816469861
PubMed Web of Science ®Google Scholar
PelatMDessyCMassionPRosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivoCirculation20031072480612719275
PubMed Web of Science ®Google Scholar
PottCSteinritzDBoeleckBeNOS-translocation but not eNOS-phosphorylation is dependent on intracellular Ca2+ in human atrial myocardiumAm J Physiol Cell Physiol2006290C1437C144516338973
PubMed Web of Science ®Google Scholar
ReidHLBarnesAJLockPJTechnical methods. A simple method for measuring erythrocyte deformabilityJ Clin Path1976298558977787
PubMed Web of Science ®Google Scholar
SchäferAFraccarolloDEigenthalerMRosuvastatin reduces platelet activation in heart failure; Role of NO bioavailabilityArterioscler Thromb Vasc Bio2005251071715761193
PubMed Web of Science ®Google Scholar
SymeonidisAAthanassiouGPsiroyannisAImpairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patientsClin Lab Haematol200123103911488849
PubMedGoogle Scholar
SzaparyLHorvathBMartonZShort-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemiaCNS Drugs2004181657214871160
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date